---
author: Marisa Aigen
category: tech
date: '2025-11-28 14:15:00'
description: 'TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone
  Biologic Inc.¬†(TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (‚ÄúNurExone‚Äù or the ‚ÄúCompany‚Äù),
  a preclinical-stage biotechnology company pioneering exosome-based therapies for
  central nervous system in‚Ä¶'
importance: 3
layout: tech_news_article
original_title: NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results
  and Provides Corporate Update
publishedAt: '2025-11-28T14:15:00+00:00'
slug: nurexone-biologic-inc-announces-third-quarter-2025
source:
  emoji: üì∞
  id: null
  name: GlobeNewswire
title: NurExone Biologic Inc. Announces Third Quarter 2025 Financial Results and Provides
  Corporate Update
url: https://www.globenewswire.com/news-release/2025/11/28/3196317/0/en/NurExone-Biologic-Inc-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
urlToImage: https://ml.globenewswire.com/Resource/Download/1514c671-cc84-4bcb-82d7-b834fce40882
urlToImageBackup: https://ml.globenewswire.com/Resource/Download/1514c671-cc84-4bcb-82d7-b834fce40882
---

TORONTO and HAIFA, Israel, Nov. 28, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc.¬†(TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (‚ÄúNurExone‚Äù or the ‚ÄúCompany‚Äù), a preclinical-stage biotechnology company pioneering exosome-based therapies for central nervous system in‚Ä¶

---

[ƒå√≠st p≈Øvodn√≠ ƒçl√°nek](https://www.globenewswire.com/news-release/2025/11/28/3196317/0/en/NurExone-Biologic-Inc-Announces-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html)

**Zdroj:** üì∞ GlobeNewswire
